1. Home
  2. GEMI vs ALLO Comparison

GEMI vs ALLO Comparison

Compare GEMI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gemini Space Station Inc.

GEMI

Gemini Space Station Inc.

HOLD

Current Price

$5.17

Market Cap

536.3M

Sector

N/A

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.28

Market Cap

539.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEMI
ALLO
Founded
2014
2017
Country
United States
United States
Employees
650
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
536.3M
539.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
GEMI
ALLO
Price
$5.17
$2.28
Analyst Decision
Buy
Strong Buy
Analyst Count
9
15
Target Price
$8.31
$8.35
AVG Volume (30 Days)
1.5M
15.1M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.09
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.05
N/A
Revenue Next Year
$39.56
$142,416.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.91
$0.86
52 Week High
$34.67
$4.46

Technical Indicators

Market Signals
Indicator
GEMI
ALLO
Relative Strength Index (RSI) 54.87 48.95
Support Level $4.01 $2.12
Resistance Level $5.24 $2.67
Average True Range (ATR) 0.32 0.13
MACD 0.14 0.00
Stochastic Oscillator 86.69 48.81

Price Performance

Historical Comparison
GEMI
ALLO

About GEMI Gemini Space Station Inc.

Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: